Frontiers in Oncology (Dec 2022)

Case Report: Stage IIIc primary malignant mixed Müllerian tumor of the fallopian tube: A case of 5-year disease-free survival after cytoreductive surgery combined with peritoneal resection and adjuvant chemotherapy with paclitaxel plus carboplatin

  • Xiaoli Xiao,
  • Ruiqing Ma,
  • Lianyao Shi,
  • Cong Wang,
  • Jie Chen,
  • Yiyan Lu,
  • Yufeng Wang,
  • Xichao Zhai,
  • Fengxian Fu

DOI
https://doi.org/10.3389/fonc.2022.1054307
Journal volume & issue
Vol. 12

Abstract

Read online

Malignant mixed Müllerian tumor (MMMT) of the fallopian tube is rare and has a poor prognosis. For the patient with fallopian tube MMMT, complete resection of the tumor invading the viscera and the peritoneum is a prerequisite for long-term survival. We report a case of stage IIIc MMMT of the fallopian tube treated by cytoreductive surgery (CRS), peritoneal resection, and adjuvant chemotherapy (paclitaxel plus carboplatin), with 5-year tumor-free survival. Postoperative chemotherapy combining platinum and paclitaxel is the most potent adjuvant therapy.

Keywords